zacks.com · Sep 22, 2026
ABBVIE INC. COVERAGE
Latest AbbVie Inc. news
Around the market
fool.com · Sep 22, 2026
AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
Read article →
247wallst.com · Sep 22, 2026
3 Dividend Stocks to Buy Before September Ends and Hold Forever
Read article →
gurufocus.com · Sep 22, 2026
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
Read article →
247wallst.com · Sep 21, 2026
How Much Do You Really Need Invested to Replace a $200,000 Salary With Dividends?
Read article →
fool.com · Sep 19, 2026
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?
Read article →KEY DATA POINTS
Financial snapshot
Revenue, profitability, balance-sheet, cash-flow, and valuation trends for AbbVie Inc..
NYSE MARKET COMPARABLES
Similar companies
Ten established NYSE listings presented for broader market context.
TradingView renders the market-data table. Securities.io supplies only the editorial peer selection, comparison labels, and destination links.
COMPANY DETAILS
About AbbVie Inc.
Business description, sector, industry, leadership, headquarters, and workforce information.
SECURITIES.IO RESEARCH
Continue your research
NYSE market data on this page is labeled as 15 minutes delayed. Prices, charts, financials, company information, and the peer comparison are displayed by TradingView; Securities.io does not extract those values. This information is educational and is not investment advice.